Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon α-2b (PegBeron) for inactive chronic hepatitis B virus carriers
ChiCTR2200064132Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Hepatitis B surface antigen level. Started Sep 2022; status: recruiting.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2200064132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064132.